All malignant neoplasms (140–209) |
Background | 2489 | | 1.0 | | 2649.1 | 0.9 | 0.9 to 1.0 |
Very low | 19 | 18.8 | 1.0 | 0.6 to 1.6 | 20.6 | 0.9 | 0.6 to 1.4 |
Low | 44 | 42.0 | 1.0 | 0.8 to 1.4 | 46.0 | 1.0 | 0.7 to 1.3 |
Moderate | 52 | 47.7 | 1.1 | 0.8 to 1.4 | 51.4 | 1.0 | 0.8 to 1.3 |
High | 27 | 29.5 | 0.9 | 0.6 to 1.3 | 31.7 | 0.9 | 0.6 to 1.2 |
Very high | 26 | 19.2 | 1.4 | 0.9 to 2.0 | 20.8 | 1.3 | 0.8 to 1.8 |
p value for linear trend | | | 0.33 | | | | | |
| | | | | | | | |
Cancer of the lung (162) | | | | | | | | |
Background | 843 | | 1.0 | | 893.0 | 0.9 | 0.9 to 1.0 |
Very low | 4 | 6.5 | 0.6 | 0.2 to 1.6 | 7.2 | 0.6 | 0.2 to 1.4 |
Low | 18 | 14.6 | 1.2 | 0.8 to 2.0 | 16.2 | 1.1 | 0.7 to 1.7 |
Moderate | 15 | 16.3 | 0.9 | 0.6 to 1.5 | 17.7 | 0.9 | 0.5 to 1.4 |
High | 6 | 10.4 | 0.6 | 0.3 to 1.3 | 11.2 | 0.5 | 0.2 to 1.2 |
Very high | 5 | 6.8 | 0.7 | 0.3 to 1.8 | 7.4 | 0.7 | 0.2 to 1.6 |
p value for linear trend | | | 0.27 | | | | | |
| | | | | | | | |
Soft tissue sarcoma (171) | | | | | | | | |
Background | 18 | | 1.0 | | 11.8 | 1.5 | 0.9 to 2.4 |
Very low | 0 | 0.2 | 0.0 | NA | 0.1 | 0.0 | 0.0 to 33.5 |
Low | 0 | 0.4 | 0.0 | NA | 0.3 | 0.0 | 0.0 to 14.8 |
Moderate | 0 | 0.4 | 0.0 | NA | 0.3 | 0.0 | 0.0 to 14.8 |
High | 0 | 0.2 | 0.0 | NA | 0.1 | 0.0 | 0.0 to 26.3 |
Very high | 2 | 0.1 | 15.8 | 5.2 to 47.8 | 0.1 | 21.8 | 2.7 to 80.2 |
p value for linear trend | | | 0.07 | | | | |
| | | | | | | |
Non-Hodgkin’s lymphoma (200, 202) |
Background | 82 | | 1.0 | | 84.7 | 1.0 | 0.8 to 1.2 |
Very low | 2 | 0.7 | 3.1 | 0.8 to 11.6 | 0.7 | 2.8 | 0.3 to 10.0 |
Low | 1 | 1.4 | 0.7 | 0.1 to 4.9 | 1.6 | 0.6 | 0.0 to 3.4 |
Moderate | 2 | 1.7 | 1.2 | 0.3 to 4.9 | 1.7 | 1.2 | 0.1 to 4.2 |
High | 2 | 1.0 | 2.1 | 0.5 to 8.3 | 1.1 | 1.9 | 0.2 to 6.9 |
Very high | 1 | 0.6 | 1.7 | 0.2 to 11.9 | 0.7 | 1.5 | 0.0 to 8.3 |
p value for linear trend | | | 0.31 | | | | |